European partners have launched COMBINE-CT, a project designed to close a familiar gap in medical technology: the distance between an impressive imaging innovation and a diagnostic pathway that clinicians can safely use every day. The Innovative Health Initiative (IHI) lists the project with an approximate budget of €10 million and Philips as coordinator.
That framing matters. In diagnostic imaging, technical progress is often easy to demonstrate before clinical value is. Better image quality, faster reconstruction or a more sophisticated analysis method do not automatically improve a decision for an individual patient. COMBINE-CT puts the harder question at the centre: how can advanced CT applications be clinically validated and introduced in a way that works across real care settings?
From a scan to a clinical decision
The project focuses on advanced CT approaches that can bring anatomical and functional information closer together. In cardiovascular diagnostics, that direction is especially relevant. In current practice, patients may still undergo invasive coronary angiography without a clinically significant narrowing being found. Earlier project communications have cited estimates of around 60 per cent in selected contexts. That figure is a rationale for better selection and diagnostics, not evidence that COMBINE-CT itself has already reduced invasive procedures.
COMBINE-CT is set up around five clinical studies. Their value will depend not only on the performance of the technology, but on the questions they answer: which patients benefit, which outcomes should count, how consistently can scans be acquired and interpreted, and how does a new diagnostic step affect the wider care pathway? These are the questions that determine whether an innovation is ready to move beyond a specialist centre.
For radiology departments and cardiology teams, this is a more useful definition of innovation than the usual product announcement. The relevant endpoint is not simply whether a new CT capability exists. It is whether it helps a clinician avoid uncertainty, reduce unnecessary steps or make a decision earlier without shifting risk elsewhere in the pathway.
Implementation is part of the evidence
Clinical validation cannot be separated from implementation. Hospitals differ in scanner fleets, software versions, protocols, expertise, referral patterns and patient populations. A result produced in a controlled study can therefore be difficult to reproduce when the technology is used at scale. COMBINE-CT explicitly places validation and clinical application together, which is an important signal for a European medtech sector that increasingly needs to show adoption, not only invention.
That also broadens the responsibility for implementation. The radiologist, cardiologist, medical physicist, IT team and procurement function all influence whether a new imaging workflow works safely. Interoperability with existing systems, quality assurance, reporting, capacity planning and training are not secondary details. They determine whether a technically capable tool becomes a dependable part of care.
The public project information does not establish that the technologies in COMBINE-CT already deliver better patient outcomes or lower costs. Those claims require study results and subsequent real-world evaluation. The project is consequential precisely because it recognises this evidentiary step as the work to be done, rather than treating market availability as the end point.
A European route, a local decision
IHI brings public and private partners together around healthcare research and innovation. That European scale can help align evidence generation, share expertise and reduce duplication. Yet each hospital will ultimately make a local decision: does the application improve its pathway, can the organisation deliver it reliably, and can patients access it equitably?
For health-system leaders, three outputs will be worth watching. First, which patient groups and indications show a clinically meaningful benefit. Second, which operational conditions are needed to deploy advanced CT safely and reproducibly. Third, whether the resulting approach can move beyond a limited group of well-resourced centres. If COMBINE-CT can answer those questions, it may offer a useful model for turning complex imaging innovation into practical, scalable diagnostics.
Add ICT&health on Google
Show more content from ICT&health in Google Search.
